4
IRUS Total
Downloads
  Altmetric

May Measurement Month 2019: an analysis of blood pressure screening results from the United Kingdom and Republic of Ireland

Title: May Measurement Month 2019: an analysis of blood pressure screening results from the United Kingdom and Republic of Ireland
Authors: McDonnell, BJ
Rees, E
Cockcroft, JR
Beaney, T
Clayton, B
Le Kieu, P
Brady, AJB
Padmanabhan, S
McCallum, L
Dolan, E
O'Brien, E
Tomaszewski, M
Schutte, AE
Poulter, NR
Cappuccio, FP
International Society of Hypertension and British and Irish Hypertension Society
Item Type: Journal Article
Abstract: In the UK, heart and circulatory diseases account for 29% of all deaths (14% through coronary heart disease and 8% through stroke). In 2015, the prevalence of hypertension was 20% in the UK and 23% in the Republic of Ireland. In 2019, 14% of people registered with a UK general practice had hypertension and yet it was the attributable risk factor for around half of all deaths from coronary heart disease or stroke. We participated in May Measurement Month 2019 to increase awareness of blood pressure (BP) measurement, and to identify the proportion of undiagnosed hypertension and degree of uncontrolled hypertension in the community. The 2019 campaign set up screening sites within the community at places of worship, supermarkets, GP surgeries, workplaces, charity events, community pharmacies, gyms, and various other public places. We screened 10194 participants (mean age 51 ± 18 years, 60% women) and found that 1013 (9.9%) were on antihypertensive treatment, while 3408 (33.4%) had hypertension. Of the 3408 participants with hypertension, only 33.5% were aware of their condition despite 98.8% having previous BP measurements. In those on antihypertensive medication, only 38.2% had controlled BP (<140 and <90 mmHg). Our UK and Republic of Ireland data demonstrate concerning levels of undiagnosed hypertension and sub-optimal BP control in many individuals with a diagnosis. This evidence supports a critical need for better systematic community and primary care screening initiatives.
Issue Date: 20-May-2021
Date of Acceptance: 27-Nov-2020
URI: http://hdl.handle.net/10044/1/90557
DOI: 10.1093/eurheartj/suab033
ISSN: 1520-765X
Publisher: European Society of Cardiology
Start Page: B147
End Page: B150
Journal / Book Title: European Heart Journal Supplements
Volume: 23
Issue: Suppl B
Copyright Statement: © The Author(s) 2021.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in anymedium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Keywords: Blood pressure
Control
Hypertension
Screening
Treatment
International Society of Hypertension and British and Irish Hypertension Society
Blood pressure
Control
Hypertension
Screening
Treatment
1102 Cardiorespiratory Medicine and Haematology
Cardiovascular System & Hematology
Publication Status: Published
Conference Place: England
Appears in Collections:School of Public Health



This item is licensed under a Creative Commons License Creative Commons